Deal Watch, Focus On Asia: Cipla Licenses India Rights To Lilly’s Basalgar

 
• By Ian Haydock, Anju Ghangurde, Jung Won Shin, and Joseph Haas
  
DealWatch_1200x675
DEALS CONTINUE APACE IN ASIA
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Focus On Asia

More from Scrip